🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

11 results for “Trevi Therapeutics” Clear

  1. Nalbuphine ER Tablets

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  2. nalbuphine HCl ER

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  3. nalbuphine HCl ER

    Trevi Therapeutics

    Uremic Pruritus

    phase 3 small molecule completed

    2 trials

  4. nalbuphine HCl ER tablets 60 mg BID

    Trevi Therapeutics

    Uremic Pruritus

    phase 3 small molecule completed

    1 trial

  5. nalbuphine HCl ER tablets 90 mg BID

    Trevi Therapeutics

    Prurigo Nodularis

    phase 3 small molecule completed

    1 trial

  6. NAL ER

    Trevi Therapeutics

    Refractory Chronic Cough

    phase 2 small molecule completed

    1 trial

  7. NAL ER

    Trevi Therapeutics

    Idiopathic Pulmonary Fibrosis

    phase 2 small molecule active

    3 trials

  8. Nalbuphine ER, Placebo - Nalbuphine ER, Nalbuphine ER

    Trevi Therapeutics

    Idiopathic Pulmonary Fibrosis (IPF)

    phase 2 small molecule active

    1 trial

  9. NAL ER

    Trevi Therapeutics

    Healthy Participants

    phase 1 small molecule active

    2 trials

  10. Nalbuphine ER

    Trevi Therapeutics

    Hepatic Impairment

    phase 1 small molecule completed

    1 trial

  11. Nalbuphine HCl solution

    Trevi Therapeutics

    Nalbuphine

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources